Symphony Robotics announced today that it licensed micro-robotic arm technology from Case Western Reserve University (CWRU).
Cleveland-based Symphony Robotics licensed CWRU’s novel, MRI-guided, magnetically actuated robotic platform. The technology navigates non-linear trajectories, enabling precise, micro-invasive surgeries with real-time guidance.
The company plans to advance the technology that combines micro-robotic arms, real-time computer vision and state-of-the-art AI. Its initial focus centers around providing neurosurgeons with enhanced capabilities for complex microsurgical procedures. They target brain cancer — particularly glioblastoma multiforme (GBM) — and epilepsy.
Ultimately, Symphony says it hopes to reduce incision and craniotomy size to less than 4mm. This would mark a tenfold reduction compared to current clinical norms. The technology could enable extended, precise access to deep-seated lesions while protecting the surrounding tissue.
Symphony Robotics built its ultra-maneuverable micro-robotic technology to leverage MRI capabilities and enable real-time guidance. Its product remains investigational.
“Our technology will introduce unprecedented advancements in neurosurgery,” said Mordechai (Moty) Avisar, Symphony Robotics founder and CEO. “The potential to enhance surgical precision and improve patient outcomes is truly groundbreaking. Neurosurgeons will be able to perform highly targeted procedures on deep-seated pathologies through significantly smaller surgical openings—down to the micro level—while navigating complex, geometrically dispersed pathologies with greater safety and accuracy.”
